General Information of the Compound
| Compound ID |
CP0863601
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
3-endo-(8-{2-[cyclopentylmethyl-(3-hydroxypropionyl)amino]ethyl}-8-azabicyclo[3.2.1]oct-3-yl)-benzamide trifluoroacetate salt
Show/Hide
|
||||||||||||||||||
| Formula |
C27H38F3N3O5
|
||||||||||||||||||
| Molecular Weight |
541.611
|
||||||||||||||||||
| Canonical SMILES |
NC(=O)c1cccc([C@H]2C[C@H]3CC[C@@H](C2)N3CCN(CC2CCCC2)C(=O)CCO)c1.O=C(O)C(F)(F)F
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C25H37N3O3.C2HF3O2/c26-25(31)20-7-3-6-19(14-20)21-15-22-8-9-23(16-21)28(22)12-11-27(24(30)10-13-29)17-18-4-1-2-5-18;3-2(4,5)1(6)7/h3,6-7,14,18,21-23,29H,1-2,4-5,8-13,15-17H2,(H2,26,31);(H,6,7)/t21-,22+,23-;
Show/Hide
|
||||||||||||||||||
| InChIKey |
GRDKNMCNTZUFSC-JCNHLJMTSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01188, Kappa-type opioid receptor
Protein ID: PT01515, Mu-type opioid receptor